Skip to content

CorMedix CRMD Foreign currency translation

Foreign currency translation at other companies

CorMedix logo
CorMedixCRMD
-$25K
Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
-$50K+50.0%
Babcock & Wilcox Enterprises logo
Babcock & Wilcox EnterprisesBW
-$101K+74.9%
V2X logo
V2XVVX
-$657K-115%
IBEX Limited logo
IBEX LimitedIBEX
-$1.12M-400%
Proto Labs logo
Proto LabsPRLB
$1.7M+3,088%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossAfterTax.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's foreign currency translation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's foreign currency translation?
CorMedix (CRMD) reported foreign currency translation of -$25K in Q4 2025.
What is the long-term trend for CorMedix's foreign currency translation?
Over 2 years (2023 to 2025), CorMedix's foreign currency translation has grown at a 671.1% compound annual growth rate (CAGR), from $1.68K to -$100K.
What does foreign currency translation mean?
The net gain or loss resulting from fluctuations in exchange rates on transactions denominated in currencies other than the company's functional currency. This reflects the company's exposure to international market volatility.